Dosage forms & technologies
UPM develops and manufactures the full range of oral solid dosage forms, with formulation and processing capabilities that span immediate- and modified-release products.
Tablets & capsules
- Tablets — immediate-release, modified-/extended-release, multi-layer, and coated tablets.
- Capsules — powder- and pellet-filled hard-shell capsules.
Release profiles & powder processing
- Release profiles — immediate-release (IR) and modified-release (MR/ER) formulation design, including matrix and functional-coating approaches.
- Powder processing — blending, granulation (wet/dry), milling, and compression.
From clinical supply to commercial production
UPM’s infrastructure spans the full lifecycle: clinical trial material, registration/validation batches, and commercial-scale production running programs that range from early-stage development batches to high commercial volumes. This continuity lets sponsors keep one manufacturing partner from first-in-human through launch and beyond — reducing tech-transfer risk at the most fragile hand-off points.
Quality, compliance & containment
Regulatory registrations
- cGMP, FDA-registered facility.
- DEA-registered for controlled substances.
Containment & analytical support
- High-potency / containment handling.
- Analytical development, release, and stability testing supporting each program.
Packaging & lifecycle management
Bottle and blister packaging, serialization, labeling, and post-approval lifecycle support (site transfers, scale changes, and ongoing CMC maintenance).